the impact of esp on neurophysiological monitoring in scoliotic patients

Conditions: Neurophysiological Monitoring Under TIVA

Summary: scoliosis surgery requires intraoperative neuromonitoring. electrophysiological monitors used include somatosensory evoked potentials (seps) and motor-evoked potentials (meps). meps are a measured muscular contraction produced by stimulation of the motor cortex via electrodes to the scalp. evoked electromyography (emg) of pedicle screws allows for evaluation of potential injury from incorrect screw placement. anaesthetic agents: volatile agents produce dose-related decreases in amplitude of meps. meps are also stopped with the use of neuromuscular blockade (nmb). it is accepted that an initial dose of a nmb agent will be metabolised before monitoring is required. therefore a tiva technique is the recommended anaesthetic technique for this procedure. propofol has been shown to attenuate mep signals and should be kept in mind. this effect can be mitigated with the use of ketamine which increases sep and mep amplitudes. benzodiazepines as well as opioids (including intrathecal opioids) have been shown to have minimal effect on signals. α2 agonists attenuate mep amplitudes (3). accordingly, the goals of spine correction surgery include hemodynamic stability with no interference in neuromonitoring and optimal pain control. multimodal analgesia is recommended in the preoperative intraoperative and postoperative periods. intrathecal morphine has been shown to reduce pain scores and allow for improved postoperative analgesia. remifentanil infusions are used to reduce propofol requirements thus improving neuromonitoring. hyperalgesia has been noted but various strategies can be used to mitigate this. intravenous lignocaine and ketamine have been shown to reduce opioid requirements. the use of α2 agonists help to reduce opioid requirements but can attenuate neuromonitoring signals. postoperative administration of extensive amounts of opioids can cause well known side-effects, such as respiratory depression, sedation, pruritis, nausea, vomiting, and constipation. ileus is also a common complication due to the nature of the surgery and opioid use in the perioperative period. even with opioids, pain is not always sufficiently managed. inadequate pain control increases cardiac and respiratory complications, delays mobilization, increases the length of hospital stay and may increase the risk of developing a chronic pain syndrome . the above mentioned complications indicate the need for a novel regional anesthesia techniques. until recently, regional anesthesia techniques have not been used on a regular basis in spine surgery as an immediate postoperative neurological examination is required. this examination of the motor and sensory function of the spinal cord eliminates spinal and epidural analgesia as suitable pain treatments. novel interfascial plane blocks, such as the erector spinae plane (esp) block, generate regional analgesia without interference of spinal cord function and are therefore suitable for spinal surgery pain management . an esp block has a very low risk of complications, as sonoanatomy is easily recognizable and there are no structures in close proximity at risk of needle injury. the transverse process acts as an anatomical barrier and avoids needle insertion into the pleura or vessels, thus preventing a pneumothorax or hematoma. moreover, the needle is relatively far from the vertebral canal, which means the risk of spinal cord injury is very low. it is applied preoperatively before skin incision as a preemptive analgesia so it suppresses chronic sensitization process. in addition, it may abolish the neuroendocrine stress response by decreasing release of the counterregulatory hormones like catecholamines the mechanism by which it may augment controlled hypotensive anaesthesia


Eligibility criteria:
inclusion criteria: * patients with american association of anesthesiologists up to iii physical status undergoing scoliosis repair under tiva. exclusion criteria: * patients with an asa status above iii. * patient or guardian refusal to participate, patients with multiple congenital anomalies. * hypersensitivity or contraindication to the study drugs. * severe restrictive pulmonary disease indicating postoperative ventilation.